Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.6. Major Market Findings
2.6.1. Cardiology Is The Fastest-Growing Rnai Drug Delivery Application
2.6.2. Nanoparticle Drug Delivery Is The Majorly Preferred Rnai Drug Delivery Technology

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Demand For Rna-Based Therapeutics To Stimulate Market Growth
3.1.2. Rising Prevalence Of Chronic Diseases Fosters Market Demand
3.1.3. Growing Investment In Rna-Based Research To Escalate The Market Growth
3.2. Key Restraints
3.2.1. The Complexity Of Rnai Technology Is Predicted To Hinder Market Demand
3.2.2. Regulatory Challenges Are Expected To Further Complicate Market Growth

4. Key Analytics
4.1. Key Market Trends
4.1.1. Rnai Drugs Have Applications In Cancer Treatment
4.1.2. Infectious Diseases Are Leading To Increased Traction In Rnai Drugs
4.1.3. Venture Funding For Rnai Drugs Has Increased Substantially
4.2. Porter’S Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.3.1. Growth Prospect Mapping For South Korea
4.4. Market Maturity Analysis
4.5. Market Concentration Analysis
4.6. Value Chain Analysis
4.6.1. Primary Activities
4.6.1.1. Research And Development (R&D)
4.6.1.2. Manufacturing
4.6.1.3. Logistics And Distribution
4.6.1.4. Marketing And Sales
4.6.1.5. After-Sales Service
4.6.2. Support Activities
4.6.2.1. Procurement
4.6.2.2. Technology Development
4.6.2.3. Human Resource Management
4.6.2.4. Firm Infrastructure
4.6.2.5. Regulatory Affairs And Compliance
4.7. Key Buying Criteria
4.7.1. Efficacy And Safety
4.7.2. Mechanism Of Action And Target Specificity
4.7.3. Delivery System And Administration Route
4.7.4. Competitive Advantage And Differentiation
4.7.5. Regulatory Approval And Compliance
4.7.6. Cost And Reimbursement
4.7.7. Intellectual Property And Exclusivity
4.7.8. Manufacturing Capabilities And Supply Chain
4.7.9. Company Reputation And Experience

5. Market By Application
5.1. Oncology
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Infectious Disease
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Neurology
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis
5.4. Cardiology
5.4.1. Market Forecast Figure
5.4.2. Segment Analysis
5.5. Metabolic Disorders
5.5.1. Market Forecast Figure
5.5.2. Segment Analysis
5.6. Ophthalmology
5.6.1. Market Forecast Figure
5.6.2. Segment Analysis
5.7. Urology
5.7.1. Market Forecast Figure
5.7.2. Segment Analysis
5.8. Other Applications
5.8.1. Market Forecast Figure
5.8.2. Segment Analysis

6. Market By Technology
6.1. Nanoparticle Drug Delivery
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Pulmonary Drug Delivery
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Nucleic Acid Drug Delivery
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis
6.4. Aptamer Drug Delivery
6.4.1. Market Forecast Figure
6.4.2. Segment Analysis

7. Competitive Landscape
7.1. Key Market Strategies
7.1.1. Product Launches & Developments
7.1.2. Partnerships & Agreements
7.2. Company Profiles
7.2.1. Alnylam Pharmaceuticals Inc
7.2.1.1. Company Overview
7.2.1.2. Product Portfolio
7.2.1.3. Strengths & Challenges
7.2.2. Arbutus Biopharma Corp
7.2.2.1. Company Overview
7.2.2.2. Product Portfolio
7.2.2.3. Strengths & Challenges
7.2.3. Ionis Pharmaceuticals Inc
7.2.3.1. Company Overview
7.2.3.2. Product Portfolio
7.2.3.3. Strengths & Challenges
7.2.4. Sirnaomics Inc
7.2.4.1. Company Overview
7.2.4.2. Product Portfolio
7.2.4.3. Strengths & Challenges
7.2.5. Silence Therapeutics Plc
7.2.5.1. Company Overview
7.2.5.2. Product Portfolio
7.2.5.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For South Korea
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Value Chain Analysis
Figure 7: Key Buying Criteria
Figure 8: South Korea Rna Interference (Rnai) Drug Delivery Market, Growth Potential, By Application, In 2023
Figure 9: South Korea Rna Interference (Rnai) Drug Delivery Market, By Oncology, 2024-2032 (In $ Million)
Figure 10: South Korea Rna Interference (Rnai) Drug Delivery Market, By Infectious Disease, 2024-2032 (In $ Million)
Figure 11: South Korea Rna Interference (Rnai) Drug Delivery Market, By Neurology, 2024-2032 (In $ Million)
Figure 12: South Korea Rna Interference (Rnai) Drug Delivery Market, By Cardiology, 2024-2032 (In $ Million)
Figure 13: South Korea Rna Interference (Rnai) Drug Delivery Market, By Metabolic Disorders, 2024-2032 (In $ Million)
Figure 14: South Korea Rna Interference (Rnai) Drug Delivery Market, By Ophthalmology, 2024-2032 (In $ Million)
Figure 15: South Korea Rna Interference (Rnai) Drug Delivery Market, By Urology, 2024-2032 (In $ Million)
Figure 16: South Korea Rna Interference (Rnai) Drug Delivery Market, By Other Applications, 2024-2032 (In $ Million)
Figure 17: South Korea Rna Interference (Rnai) Drug Delivery Market, Growth Potential, By Technology, In 2023
Figure 18: South Korea Rna Interference (Rnai) Drug Delivery Market, By Nanoparticle Drug Delivery, 2024-2032 (In $ Million)
Figure 19: South Korea Rna Interference (Rnai) Drug Delivery Market, By Pulmonary Drug Delivery, 2024-2032 (In $ Million)
Figure 20: South Korea Rna Interference (Rnai) Drug Delivery Market, By Nucleic Acid Drug Delivery, 2024-2032 (In $ Million)
Figure 21: South Korea Rna Interference (Rnai) Drug Delivery Market, By Aptamer Drug Delivery, 2024-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – RNA INTERFERENCE (RNAI) DRUG DELIVERY
TABLE 2: SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS